Company Performance Metrics
Snoretox develops therapeutic inventions aimed at improving the quality of life for individuals suffering from muscle tone disorders and obstructive sleep apnea. The company leverages RMIT-developed technology to create a novel muscle toning toxin-based therapeutic. Snoretox's innovative approach uses minute amounts of tetanus toxin to tone
and tighten muscles, contrasting with Botox's muscle-relaxing properties. The company collaborates with RMIT University to pioneer the world's first injectable solution for treating obstructive sleep apnea and other related conditions.